ChartMill assigns a Buy % Consensus number of 85% to NAGE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-06-06 | Roth Capital | Maintains | Buy -> Buy |
| 2025-05-27 | Canaccord Genuity | Initiate | Buy |
| 2025-04-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
11 analysts have analysed NAGE and the average price target is 16.12 USD. This implies a price increase of 168.15% is expected in the next year compared to the current price of 6.01.
The consensus rating for NIAGEN BIOSCIENCE INC (NAGE) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering NIAGEN BIOSCIENCE INC (NAGE) is 11.